https://www.globallymealliance.org/news/the-kay-hagan-tick-reauthorization-act-is-signed-into-law-what-this-means?

Kay Hagan Tick Act Reauthorized: What It Means for Lyme Disease

by Admin at Global Lyme Alliance on October 1, 2026

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >Kay Hagan Tick Act Reauthorized: What It Means for Lyme Disease</span>
On September 30, 2026, The Kay Hagan Tick Reauthorization Act was signed into law, extending federal funding for tick-borne diseases until 2030. Here’s what it means:

“With the Kay Hagan Tick Act now law, we have an important opportunity to build on the progress made in addressing Lyme and other tick-borne diseases,” says Jennifer Katritos, Chief Executive Officer of Global Lyme Alliance.

“Sustained federal investment in surveillance, research, and state and local public health efforts is critical to advancing the science and building the foundation for meaningful breakthroughs. Global Lyme Alliance is grateful to the bipartisan leaders who championed this legislation, and we stand ready to support these efforts while continuing to advance the research that can lead to earlier and more accurate diagnoses, better treatments, and ultimately, fewer people impacted by these diseases.”

Named for the former Senator Kay Hagan of North Carolina, who died following complications from Powassan virus encephalitis, a rare tick-borne disease, the original Kay Hagan Tick Act was signed into law in 2019.

What will the Kay Hagan Tick Reauthorization Act do:
  • Reauthorize Regional Centers of Excellence in Vector-Borne Diseases for five years. These university-based hubs at the University of Massachusetts Amherst, University of California, Davis, University of Florida, and the University of Wisconsin-Madison conduct research on ways to prevent tick and mosquito bites, or suppress populations of regionally important ticks and mosquitoes and their associated human disease pathogens. The centers also provide training for public health entomologists to serve as experts in vector-borne diseases, and spearheaded the creation of regional vector surveillance systems for centralized data tracking.
  • Reauthorize Centers for Disease Control and Prevention (CDC) grants to state health departments to strengthen data collection and analysis, support early detection, improve treatment, and increase public education and partnerships addressing Lyme disease and other vector-borne diseases.
  • Continue implementing and updating the U.S. Department of Health and Human Services’ National Public Health Strategy to Prevent and Control Vector-Borne Diseases in People. These efforts have been key in expanding research into tick-borne diseases, improving testing and diagnostics, and coordinating efforts across the federal government.

Sources:

https://www.collins.senate.gov/newsroom/signed-into-law-kay-hagan-tick-reauthorization-act-authored-by-senator-collins

https://www.cdc.gov/vector-borne-diseases/what-cdc-is-doing/centers-of-excellence-in-vector-borne-diseases.html

________________

**Comment**

Willy Burgdorfer said it correctly when he stated that the money continues to go to the same people with the same results: which is NOTHING.

Bingo.

Don’t be fooled into thinking this “Tick Act” will do anything for patients. It will only continue to line the pockets of sold out researchers who follow a narrative. The research done in Lymeland has always been extremely biased and protective of the very agencies setting all the ‘guidelines’ which hamstring doctors into following a faulty paradigm, with testing that misses 90% or more of cases and completely dismisses the sickest ones who will never test positive on a test that is a complete joke.

The only progress we have made is when independent researchers do the work. They are not beholden to government grants and agencies who superimpose a faulty agenda upon the populace, mainly that Lyme is is caused by one organism which is cured by one drug in a short period of time. Research and reality show otherwise. Time to call a spade a spade.

For more:

https://www.lymedisease.org/diagnosis-changed-everything/

“D-Day” and the diagnosis that changed everything

Oct. 21, 2026

By Darlene DiBara O’Connor

A door closed. Then another swung wide open.

Wait.What?

You mean I might not really have ALS? I am not going to die a slow, painful death in my forties? And will still be here to raise my two young sons?

So, wait. Even after seeing 22+ practitioners, undergoing dozens of diagnostic procedures, and having numerous negative Lyme disease tests, I could still have it?

And it could be what is killing me right now?

These were the frantic questions, fraught with confusion and exhausting emotions that swirled in my brain or out of my mouth in that doctor’s office on October 16, 2013. The day after my mother’s funeral. That day that changed the course of my life–and my family’s lives–forever.

That day was what I now call my D-Day. The day that I was finally, properly diagnosed and then, successfully treated, by a brilliant and caring doctor from Connecticut. That visit saved my life, my sons’ lives, and many others in our family and beyond. This altered the course of my life. Forever.

Earlier that week, in the middle of the night, I bellowed the most guttural sobs while I prayed, on my hands and knees on my cold, kitchen floor. I vowed out loud to God, my dying mother’s mother, and the blessed St. Anne, that if WHATEVER “it” was that I really had, and was killing me, was truly revealed to me, I would beat it. And IF, whatever it was, was shown to me, I promised that I would dedicate the rest of my life to helping others with ‘it,’ also.

Oh, it was absolutely revealed to me. And I did get better. A lot better. And I kept my promise. (See link for article)

_________________

**Comment**

Yet another misdiagnosed Lyme/MSIDS patient who got well after getting the proper diagnosis and treatment.

Here’s some more:

I could go onto infinity with stories of misdiagnosis. Sadly, we are no better off than we were when it was first ‘discovered’ in the 80’s.

https://www.midwesterndoctor.com/p/what-modern-light-bulbs-are-doing?

What Modern Light Bulbs Are Doing to Us

Decades of forgotten research show natural light is an essential nutrient, and the bill to bring back incandescent bulbs just cleared its first vote

A Midwestern Doctor

Oct. 29, 2026

Story at a Glance:

•Sunlight is one of the most important things for our health (e.g., avoiding it makes you 60% more likely to die), yet all we ever hear is how important it is to avoid it.

•Energy efficient light bulbs emit a narrow, blue-heavy spectrum that disrupts sleep and metabolism, while lacking the infrared our mitochondria depend upon.

•Decades of forgotten research (now being confirmed by modern studies) show unnatural light is a root cause of many inexplicable physical and behavioral illnesses.

•The eyes and the blood conduct light throughout the body, and when this process is disrupted (e.g., by glasses), significant illnesses can develop.

•In 2022, incandescent bulbs were effectively banned because their infrared was scored as “waste.” The Senate bill to bring them back has now cleared its first committee vote.

The Importance of Sunlight

Prior to dermatology’s war on the sun (which is immensely misguided as dangerous skin cancers are due to a lack of sunlight exposure), the value of sunlight was widely recognized in medicine. For example, in the early 1900s, heliotherapy (sunbathing) was used with great success for treating many otherwise incurable conditions such as the 1918 influenza1 and tuberculosis.1 The existing data in turn shows sunlight provides an immense degree of benefit:

•A large study found high solar UVB exposure halved one’s risk of breast and prostate cancer.1

•A 20-year study of 29,518 women found that avoiding the sun made one 60% more likely to die, with the greatest benefit of regular sun exposure being a reduced risk of dying from heart disease.1 Likewise, in a 2024 analysis of the UK Biobank, both measures of UV exposure that were examined were associated with a lower risk of dying from any cause, from cardiovascular disease and from cancer,1 and when 88,905 participants wore light sensors for a week, those with brighter days and those with darker nights were each less likely to die over the following 8 years.1

•Sunlight is critical for mental health, and many workers suffer immensely without it (e.g., in hospital night shift workers, a lack of sunlight exposure was linked to worse mental health1).

Note: I really got this point once, where after a long period of hospital night shifts under fluorescent lights, I noticed I was becoming clinically depressed (which has never otherwise happened to me). I went home and bathed under a full spectrum bulb, at which point I almost instantly felt better.

Typically, sunlight’s benefits are attributed to vitamin D. However, I have long suspected that many of the benefits of vitamin D are not due to the vitamin itself but rather that its elevation indicates the body is having regular sunlight exposure. For example, when 24 healthy volunteers were exposed to UVA (which does not produce vitamin D) at a dose equivalent to about 30 minutes of summer sun, their arteries dilated and their blood pressure dropped, as nitric oxide stored in the skin was released into the circulation.1 Similarly, a meta-analysis found that spending an hour or more a day in the summer sun was associated with a 16% lower risk of breast cancer, whereas simply living somewhere with more ambient UV was not.1 (See link for article)

_________________

**Comment**

Excellent article that I can not recommend enough.

The importance of light pertains to all, but especially those of us in the Northern Latitude, like Wisconsin.

For more:

https://justusrhope.substack.com/p/the-daily-pills-that-stop-cancer

The Daily Pills that Stop Cancer

AI Refines the Root Detox™ Protocol

Justus R. Hope

Apr 02, 2025

∙ Paid

Revised Protocol Risk Reductions

Thursday Dr. Paul E. Marik and I announced an all-supplement daily cocktail that reduced cancer risk by some 60%. We improved on this with Metformin, Ivermectin, and Mebendazole to reduce risk to the 70 to 80% range.

Today we announce revisions accomplished over the past few days with the assistance of AI.

Without this time-saving help, these revisions would have taken months. But we do not have months to spare as the world is dealing with an unprecedented uptick in cancers. Everyone needs this information now.

We will begin at the beginning, starting with our first 3-Supplement AI search on Cancer Risk that established the baseline. We will end with the 90 to 95 percent Optimal Cancer Risk Reduction Protocol, that we display above and once again, with analysis, at the conclusion. (See link for article)

________________

**Comment**

I learned something new. (Well, to be fair I’m always learning something new!)

I learned that it’s important to take enteric capsules of berberine, for the same reasons your proteolytic enzymes need to be enteric: to protect the supplement from stomach acid, allowing it to be dissolved in the intestines to enhance absorption and effectiveness. Berberine also outperformed Metformin.

Users in berberine clinical literature consistently report effects on energy metabolism and AMPK activation beginning to appear at the 6-8 weeks mark with consistent daily use. The most significant observations typically occur in the 6-12 week window. Source

Enter the Root6™ OTC Protocol:

Root6™ is nothing more than our basic four + Berberine and Sulforaphane. But because of synergy, the Cancer Risk Reduction is magnified, which is why cocktails of repurposed drugs work so well against cancer (very similar to how effectively they work against HIV compared with monotherapy).

Keep in mind the Root6™ is all OTC. Source

https://zenodo.org/records/23666330

Published October 26, 2026 | Version v1

Preprint Open

mRNA Vaccine Shedding: Internal Transcriptional Dissemination and Potential Human-to-Human Transfer

Authors/Creators

Description
Abstract

COVID-19 mRNA vaccines direct host cells to manufacture prefusion-stabilized SARS-CoV-2 spike protein that retains its furin cleavage site and carries two proline substitutions (K986P/V987P) in S2 that are not present in wild-type SARS-CoV-2 spike protein. This review examines two distinct forms of mRNA vaccine shedding: (i) molecular transcriptional shedding, involving the production, proteolytic fragmentation, persistence, and dissemination of vaccine-derived molecular products within vaccinated individuals through cellular division, extracellular release, and vesicular transport; and (ii) human-to-human shedding, involving the potential transfer of these products from vaccinated individuals to other individuals through biological secretions. Evidence supporting internal molecular dissemination includes circulating spike protein, proteolytically released fragments, vaccine-derived mRNA, and spike-bearing extracellular vesicles capable of transporting molecular cargo beyond its original cellular source. Human studies document circulating S1 within 24 hours, spike-bearing exosomes by day 14, vaccine mRNA in plasma for up to 28 days, vaccine-derived spike peptides at 69–187 days, spike protein in monocytes at 852 days, circulating spike at 1,173 days, exosomal vaccine mRNA at 1,284 days, and spike protein alongside plasmid-associated DNA sequences in skin at 1,364 days. N1-methylpseudouridine-associated +1 ribosomal frameshifting generates unintended translation products, expanding the repertoire of molecules potentially available for extracellular release. The proposed internal dissemination model incorporates two additional pathways: mitotic inheritance, whereby daughter cells may inherit an altered proteome following cellular division, and exosome-mediated communication, whereby molecular cargo may affect cells that never directly received vaccine mRNA. Experimental studies demonstrate spike-mediated interference with five interconnected molecular systems—coagulation, receptor–renin–angiotensin signaling, innate immune sensing, tumor-suppressor transcription, and vesicular interferon signaling. Together, these findings identify multiple pathways through which persistent vaccine-derived molecular products could disrupt cellular regulation, propagate abnormal signaling between cells, and potentially sustain downstream biological disturbances. Regarding human-to-human shedding, vaccine-derived mRNA has been detected in trace, fragmented form within breast-milk extracellular vesicles, establishing its presence in a biological secretion transferred between individuals. Extracellular vesicles are also present in saliva, exhaled breath, sweat, semen, and other bodily secretions. Their capacity to protect molecular cargo, survive biological barriers, enter recipient cells, and deliver functional mRNA provides a biologically plausible pathway for wider interpersonal transfer. An observational study further reported associations between proximity to vaccinated individuals and menstrual irregularities among unvaccinated women. However, no published study has directly demonstrated transfer of vaccine-derived spike protein, mRNA, or plasmid-associated DNA between individuals through respiratory emissions, saliva, sweat, or other non-milk secretions, leaving a critical evidence gap concerning the extent and biological consequences of human-to-human shedding. Collectively, these findings support intracellular and intercellular dissemination of vaccine-derived molecular products, with evidence of persistence extending over multiple years. The convergence of proteolytic fragmentation, vesicular transport, and potential mitotic inheritance suggests mechanisms through which molecular products and their downstream signaling effects could extend beyond the original cells of production. Direct experimental studies are needed to establish the functional consequences of long-term persistence, determine whether these pathways sustain molecular disturbances across cellular generations, and establish whether biologically significant human-to-human transfer occurs through additional bodily secretions and, if so, its extent.

For more:

Go here to listen to Nicolas Hulscher, MPH, explain the study.